Anti-CD117 CAR T cells engineered with the SB vector showed anti-leukemic activity in a human tumor xenograft model and completely depleted healthy HSPC in immunodeficient mice reconstituted with a human hematopoiesis. Here, KIT is linked to neoplasm.